Research has yet to confirm a link between diet and psoriasis. But some psoriasis patients find that eliminating certain ...

AbbVie’s Skyrizi took home the top spot for most pharma brand ad impressions in April 2025, according to data released by ...

Pronounced “soh-TIK-too,” SOTYKTU is a once-daily pill for adults with moderate to severe plaque psoriasis that works inside ...

Once-daily roflumilast foam significantly improves scalp and body psoriasis in 8 weeks and was well-tolerated in adolescents ...

Using an existing steroid-free topical foam daily significantly improved the signs and symptoms of psoriasis on the scalp and ...

A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the ...

New study suggests a psoriasis drug could help slow or prevent Type 1 diabetes. Researchers target TYK2, an ...

A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the ...

The impact of psoriasis on quality of life goes beyond clinical measures, such as psoriasis area severity index (PASI) and ...

The biosimilar SYSA1902 is similar to reference ustekinumab for both efficacy and safety measures among patients with plaque psoriasis.

On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...

Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...